Electrochemiluminescence (ECL) · Phospho-Protein Detection

IRS-1 · IGF-1R · IR · Akt · GSK-3β

MSD Insulin Signaling Pathway Assay Services

Q: What sample preparation steps are critical for phospho-protein preservation?

Three non-negotiable requirements: (1) Phosphatase inhibitors in lysis buffer — sodium orthovanadate (tyrosine phosphatases), sodium fluoride (serine/threonine phosphatases), β-glycerophosphate. Without them, phospho-signals decay within minutes. (2) Cold processing — pre-chilled PBS, lysis buffer, and tubes at 4°C. (3) Rapid freezing — snap-freeze lysates in liquid nitrogen or dry ice/ethanol bath; store at −80°C. For insulin stimulation experiments, standardize stimulation time (typically 5–30 min at 100 nM insulin), lysis timing, and protein concentration across all samples. We provide detailed phospho-protein collection protocols during study design.

Quantify total and phosphorylated insulin signaling proteins — IRS-1, IGF-1R, IR, Akt, and GSK-3β — using electrochemiluminescence (ECL), the only multiplex platform that measures phospho-proteins and total proteins simultaneously from a single 25 µL cell or tissue lysate sample.

Insulin resistance — the fundamental defect in type 2 diabetes — is not a single-protein phenomenon but a network-level disruption of the insulin signaling cascade. Insulin binds its receptor (IR) → IRS-1 is phosphorylated → PI3K/Akt pathway is activated → GSK-3β is inhibited → glucose uptake and glycogen synthesis proceed. At each node, phosphorylation status determines signal propagation or blockade. Western blotting — the traditional method for phospho-protein analysis — is semi-quantitative, low-throughput, and requires separate blots for total and phospho forms. MSD multiplex assays quantify total and phosphorylated proteins in the same well, providing a quantitative, reproducible, and scalable readout of insulin signaling across the entire pathway — from receptor through effector — in a single 25 µL sample. This is the only MSD panel purpose-built for insulin signaling research, with antibody pairs validated for both total and phospho-specific detection of each pathway node.

Inquire About Insulin Signaling Assays View Pathway Coverage

Beyond Hormone Levels — Measuring the Intracellular Response to Insulin

Measuring circulating insulin tells you how much hormone is present. Measuring insulin signaling proteins tells you whether cells are responding to it. In insulin-resistant states, circulating insulin may be high while intracellular signaling is blunted — a disconnect invisible to hormone-level assays. The insulin signaling pathway is a phosphorylation cascade: IR autophosphorylation activates IRS-1, which recruits PI3K, generating PIP3 that activates PDK1 and Akt. Akt phosphorylates GSK-3β (inactivating it) and AS160 (promoting GLUT4 translocation). At each step, phosphorylation is the molecular event that transmits the insulin signal — and dephosphorylation by phosphatases (PTP1B, PTEN, PP2A) terminates it. Measuring total protein tells you how much signaling machinery is present; measuring phospho-protein tells you how much of it is active. The ratio reveals signal transduction efficiency — the parameter that changes earliest in insulin resistance, before hormone levels or glucose tolerance deteriorates.

 Why Phospho-Protein Measurement Matters for Insulin Research
Phospho/total ratio is more sensitive than insulin levels: Akt phosphorylation at Ser473 decreases in insulin-resistant tissues before fasting insulin rises or glucose tolerance deteriorates — the signaling defect precedes the hormonal compensation.
Node-specific resistance: insulin resistance can occur at IR (receptor-level), IRS-1 (post-receptor), or Akt (downstream) — each with different implications for therapeutic targeting. Single-node measurement misses this specificity.
Multiple phospho-sites per protein: Akt has two key phosphorylation sites (Thr308 by PDK1, Ser473 by mTORC2) with different functional significance; IRS-1 has multiple serine phosphorylation sites that inhibit (not activate) signaling — requiring phospho-site-specific antibodies.
Same sample, total + phospho: MSD multiplex measures total and phospho forms in the same well — eliminating the gel loading variability and transfer efficiency issues that confound Western blot phospho/total ratio calculations.

Insulin Signaling Pathway — Node-by-Node Coverage

Pathway Node	Protein	Total Assay	Phospho Assay	Functional Role
Insulin Receptor	IR (Insulin Receptor)	Total IR	—	Receptor tyrosine kinase; insulin binding triggers autophosphorylation and kinase activation.
IGF-1 Receptor	IGF-1R	Total IGF-1R	—	Receptor tyrosine kinase for IGF-1 and IGF-2; shares downstream signaling with IR; hybrid IR/IGF-1R receptors form in insulin-resistant states.
Insulin Receptor Substrate	IRS-1	Total IRS-1	Phospho-IRS-1 (Ser312)	Docking protein linking IR to PI3K. Ser312 phosphorylation by JNK, IKKβ, or PKC inhibits IRS-1 function — a key molecular mechanism of insulin resistance driven by inflammatory signaling.
Serine/Threonine Kinase	Akt (PKB)	Total Akt	Phospho-Akt (Ser473)	Central node of insulin signaling. Ser473 phosphorylation by mTORC2 is required for full Akt activation. Phospho-Akt phosphorylates downstream substrates including GSK-3β, AS160, and FOXO transcription factors.
Glycogen Synthase Kinase	GSK-3β	Total GSK-3β	Phospho-GSK-3β (Ser9)	Constitutively active kinase that inhibits glycogen synthase. Akt phosphorylation of GSK-3β at Ser9 inactivates it, permitting glycogen synthesis. Impaired GSK-3β phosphorylation is a hallmark of hepatic insulin resistance.

The Insulin Signaling 4-Plex includes IRS-1, IGF-1R, and IR (total proteins). The Phospho-Insulin Signaling Panel expands coverage to include phospho-Akt (Ser473) and phospho-GSK-3β (Ser9). Contact us for the full available phospho-target catalog. All services are for research use only.

Why Electrochemiluminescence for Phospho-Protein Detection

MSD vs. Western Blotting

Quantitative, not semi-quantitative: ECL generates absolute signal values with 8-point standard curves — no band densitometry, no normalization artifacts, no subjective band selection.
Total + phospho in one well: eliminates gel loading and transfer variability that confounds phospho/total ratios calculated from separate Western blot lanes.
25 µL sample: a standard Western blot loads 10–30 µg protein in 10–20 µL — MSD uses similar volume but provides quantitative, multiplexed data instead of single-analyte semi-quantitative bands.
Phospho-site specificity: antibodies validated for specific phosphorylation sites (Akt Ser473, GSK-3β Ser9, IRS-1 Ser312) — no cross-reactivity with other phospho-sites on the same protein.

Sample Preparation for Phospho-Protein Analysis

Phosphatase inhibitors are mandatory: phospho-proteins are dephosphorylated within minutes of cell lysis by endogenous phosphatases. Lysis buffer must contain phosphatase inhibitor cocktails (sodium orthovanadate, sodium fluoride, β-glycerophosphate).
Cold processing throughout: all steps at 4°C to minimize phosphatase activity. Pre-chill PBS for washing, lysis buffer, and microcentrifuge tubes.
Total protein normalization: BCA or Bradford assay on clarified lysate before MSD analysis. Report phospho-protein values normalized to total protein concentration.
Sample types: cell lysates (adipocytes, myotubes, hepatocytes, iPSC-derived insulin-sensitive cells), tissue homogenates (liver, muscle, adipose), and whole-cell lysates from insulin-stimulated time-course experiments.

Service Details

Service Package

Item	Full Service	Notes
Sample Processing	Included	Phosphatase inhibitor protocols
Standard Curve	Recombinant protein calibrators	Total + phospho, per analyte
Total Protein Normalization	Included	BCA assay on all lysates
Data Report	With phospho/total ratios	Per-pathway-node analysis

For Research Use Only. Not for diagnostic procedures.

Phospho-Protein Detection: MSD vs Western Blot

Feature	MSD (Multiplex)	Western Blot
Total + Phospho in One Well	Yes — independent signals, no cross-talk	No — separate lanes or stripping/reprobing
Quantitation	Absolute (pg/mL or normalized) — 8-point standard curves	Semi-quantitative — band densitometry
Phospho/Total Ratio Precision	Within-well — no gel loading or transfer variability	Cross-lane — loading variability degrades ratio precision
Sample Throughput	96-well / ~70 sec read	Hours — gel, transfer, block, detect
Phospho-Site Specificity	Antibodies validated for specific sites (Ser473, Ser312, Ser9)	Antibody-dependent — requires phospho-site-specific primary antibodies

What You Receive

Phospho/total quantitative report — total and phospho-protein concentrations for each pathway node with phospho/total ratios (Excel + PDF)
Raw ECL data — per-well, per-spot signal values, plate maps, standard curve plots
Total protein normalization data — BCA assay results and normalized values for all samples
Phosphatase inhibitor documentation — inhibitor cocktail composition, cold-processing verification
Methods summary — formatted for manuscript Methods sections with phospho-site-specific antibody details

Why Choose Electrochemiluminescence for Insulin Signaling

Total + phospho in one well — no blotting variability: Western blot phospho/total ratios are degraded by gel loading error and transfer efficiency variation. MSD measures both forms in the same well — the analytically superior approach for ratio biomarkers
Phospho-site specificity: antibodies validated for Akt Ser473 (mTORC2 site), IRS-1 Ser312 (inhibitory site), and GSK-3β Ser9 — no cross-reactivity with other phosphorylation sites on the same protein
Quantitative, not semi-quantitative: 8-point recombinant protein standard curves provide absolute concentration values — no band densitometry, no normalization artifacts, no subjective band selection
Phosphatase inhibitor protocols included: standardized cold-processing and inhibitor cocktail protocols provided — the pre-analytical handling that determines whether your phospho-signal reflects biology or bench-top dephosphorylation
Pathway coverage from receptor to effector: IR → IRS-1 → Akt → GSK-3β — the complete insulin signaling cascade in one multiplex measurement

FAQ

Why measure phospho-proteins instead of just total protein levels?

Total protein tells you how much signaling machinery is present. Phospho-protein tells you how much of it is active. In insulin signaling, the ratio of phospho-Akt (Ser473) to total Akt is a direct readout of PI3K pathway activation — and this ratio can decrease even when total Akt levels are unchanged. Insulin resistance is characterized by normal or elevated total IRS-1 with increased inhibitory serine phosphorylation (Ser312) — a defect invisible to total-protein-only assays. MSD multiplex measures both forms in the same well, enabling phospho/total ratio calculation without the variability of parallel Western blots.

What sample preparation steps are critical for phospho-protein preservation?

Three non-negotiable requirements: (1) Phosphatase inhibitors in lysis buffer — sodium orthovanadate (tyrosine phosphatases), sodium fluoride (serine/threonine phosphatases), β-glycerophosphate. Without them, phospho-signals decay within minutes. (2) Cold processing — pre-chilled PBS, lysis buffer, and tubes at 4°C. (3) Rapid freezing — snap-freeze lysates in liquid nitrogen or dry ice/ethanol bath; store at −80°C. For insulin stimulation experiments, standardize stimulation time (typically 5–30 min at 100 nM insulin), lysis timing, and protein concentration across all samples. We provide detailed phospho-protein collection protocols during study design.

Can this panel be used with tissue samples, not just cell lysates?

Yes. Liver, skeletal muscle, and adipose tissue homogenates are compatible with the insulin signaling panel. Key considerations: (1) tissue must be flash-frozen immediately after collection to preserve phosphorylation state; (2) homogenization in phosphatase-inhibitor-containing lysis buffer with mechanical disruption (bead-beating or Polytron); (3) centrifugation at 14,000×g for 10–20 min at 4°C to clarify lysate; (4) total protein normalization by BCA before loading. For insulin-stimulated tissue — e.g., liver harvested after intraperitoneal insulin injection in mice — timing between injection and tissue collection must be standardized. Contact us for tissue-specific protocols.

Inquiry Basket